Alzheimer's patient gets back speech, bladder control and memory in drug trial

An 80-year-old Alzheimer's patient experienced remarkable temporary improvements in speech, memory, bladder control, and mobility after receiving a single dose of psilocybin in an experimental trial. The case study, published in Frontiers in Neuroscience, suggests that some cognitive and functional abilities lost to advanced dementia may be temporarily recoverable through psilocybin, though the improvements were not permanent and did not reverse the underlying disease. Researchers note the findings are preliminary and based on a single patient case, but indicate psilocybin's potential to unlock inaccessible brain functions in Alzheimer's patients.